Cargando…
Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia
Experiments performed in mice revealed that anthracyclines stimulate immunogenic cell death that is characterized by the pre-apoptotic exposure of calreticulin (CRT) on the surface of dying tumor cells. Here, we determined whether CRT exposure at the cell surface (ecto-CRT) occurs in human cancer in...
Autores principales: | Wemeau, M, Kepp, O, Tesnière, A, Panaretakis, T, Flament, C, De Botton, S, Zitvogel, L, Kroemer, G, Chaput, N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032293/ https://www.ncbi.nlm.nih.gov/pubmed/21368877 http://dx.doi.org/10.1038/cddis.2010.82 |
Ejemplares similares
-
Secreted calreticulin mutants subvert anticancer immunosurveillance
por: Liu, Peng, et al.
Publicado: (2019) -
Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients
por: Truxova, Iva, et al.
Publicado: (2020) -
Surface-exposed and soluble calreticulin: conflicting biomarkers for cancer prognosis
por: Kepp, Oliver, et al.
Publicado: (2020) -
Calreticulin mediates immune recognition of acute myeloid leukemia cells in vivo
por: Chen, Xiufen, et al.
Publicado: (2013) -
An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells
por: Senovilla, Laura, et al.
Publicado: (2013)